Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (15)

2023

  1. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment

    Pharmaceutics, Vol. 15, Núm. 8

2021

  1. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter

    Schizophrenia Research, Vol. 228, pp. 382-384

2019

  1. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels

    Neurochemistry International, Vol. 124, pp. 152-161

2017

  1. Mania preceding pancreatic cancer

    Actas espanolas de psiquiatria, Vol. 45, Núm. 1, pp. 39-46

  2. Manía y cáncer de páncreas

    Actas Espanolas de Psiquiatria

2016

  1. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients

    Pharmacogenomics, Vol. 17, Núm. 8, pp. 837-851

2013

  1. The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients

    PLoS ONE, Vol. 8, Núm. 4

2012

  1. Aripiprazole reverses Paliperidoneinduced Hyperprolactinemia

    Actas Espanolas de Psiquiatria, Vol. 40, Núm. 5, pp. 290-292

  2. ¿por qué no hablamos de síntomas psicóticos negativos en el trastorno afectivo bipolar?

    Revista de Psiquiatria y Salud Mental

2011

  1. Variability of plasma homovanillic acid over 13 months in patients with Schizophrenia; Relationship with the clinical response and the wisconsin card sort test

    Neurochemical Research, Vol. 36, Núm. 8, pp. 1336-1343

2010

  1. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients

    Neurochemistry International, Vol. 56, Núm. 6-7, pp. 774-779

  2. GABA and homovanillic acid in the plasma of schizophrenic and bipolar i patients

    Neurochemical Research, Vol. 35, Núm. 2, pp. 247-253

2009

  1. Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients

    Pharmacological Research, Vol. 59, Núm. 4, pp. 269-272

2008

  1. Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder

    Neuropsychobiology, Vol. 58, Núm. 3-4, pp. 111-117

2007

  1. Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, Núm. 3, pp. 713-719